Maternal near-miss attributable to haemorrhagic stroke in patients with hypertensive disorders of pregnancy in Japan: A national cohort study.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 05 02 2021
revised: 28 06 2021
accepted: 19 07 2021
pubmed: 28 7 2021
medline: 15 12 2021
entrez: 27 7 2021
Statut: ppublish

Résumé

To investigate the epidemiologic and clinical characteristics of maternal near-misses attributable to haemorrhagic stroke (HS) occurring in patients with hypertensive disorders of pregnancy (HDP), with a focus on severe neurological morbidity. A national retrospective cohort study was conducted using the national database of health insurance claims for the period 2010 to 2017. The subjects were all insured women with a diagnosis of both HDP and HS. Severe neurological morbidity requiring rehabilitation, types of HDP, types of HS, and magnesium sulphate use were tabulated. The number of women with HDP who were diagnosed with HS was 3.4 per 100,000 deliveries between 2010 and 2017. Forty percent of HDP-related HS cases had neurological morbidities requiring rehabilitation (1.4 per 100,000 deliveries), and 4.4% were in a persistent vegetative state after HS. Of the HDP cases who developed HS, 69.2% were severe HDP, of which 55.6% were without eclampsia. The most common type of HS was intracerebral haemorrhage (2.5 per 100,000 deliveries), followed by subarachnoid haemorrhage due to cerebral aneurysm (1.2 per 100,000 deliveries). The frequency of magnesium sulphate use increased in all patients with HDP-related HS in the second half of the study period (2014-2017) compared with the first half (2010-2013) (p < 0.0001). This was more evident in cases of HDP-related HS with eclampsia (31.9% to 83.8%) compared to those without eclampsia (25.0% to 42.9%). Of the maternal near-miss cases due to HDP-related HS, 40.0% were rehabilitated and 69.2% were HDP without either eclampsia or severe hypertension.

Identifiants

pubmed: 34315129
pii: S2210-7789(21)00318-4
doi: 10.1016/j.preghy.2021.07.244
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-243

Informations de copyright

Copyright © 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Auteurs

Akihiko Ueda (A)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Yoshitsugu Chigusa (Y)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Haruta Mogami (H)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Baku Nakita (B)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Shosuke Ohtera (S)

Division of Medical Information Technology and Administration Planning, Kyoto University Hospital/National Institute of Public Health, Japan.

Genta Kato (G)

Solutions Centre for Health Insurance Claims, Kyoto University Hospital, Kyoto, Japan.

Akihito Horie (A)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Masaki Mandai (M)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan.

Eiji Kondoh (E)

Department of Gynaecology and Obstetrics, Kyoto University, Kyoto, Japan. Electronic address: kondo@kuhp.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH